FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28739111000001108: Rewisca 200mg capsules (Consilient Health Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Feb 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89559901000001115 Rewisca 200mg capsules (Consilient Health Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
89560001000001118 Rewisca 200mg capsules (Consilient Health Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rewisca 200mg capsules (Consilient Health Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register Exempt Safe Custody) true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Is a Product containing precisely pregabalin 200 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has active ingredient Pregabalin false Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has specific active ingredient Pregabalin true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Is a Rewisca true Inferred relationship Existential restriction modifier
Rewisca 200mg capsules (Consilient Health Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rewisca 200mg capsules (Consilient Health Ltd) 84 capsule 6 x 14 capsules Has AMP True Rewisca 200mg capsules (Consilient Health Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start